Lv5
970 积分 2023-09-01 加入
Inotuzumab Ozogamicin as Induction Therapy for Patients Older Than 55 Years With Philadelphia Chromosome-Negative B-Precursor ALL
8小时前
已完结
Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22+ Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia
8小时前
已完结
doi: 10.1007/s11864-024-01237-w. Epub 2024 Aug 5. Prediction of Response to FDA-Approved Targeted Therapy and Immunotherapy in Acute Lymphoblastic Leukemia (ALL)
8小时前
已完结
Incorporation of immunotherapy into frontline treatment for adults with B-cell precursor acute lymphoblastic leukemia
8小时前
已完结
Acute lymphoblastic leukaemia
9小时前
已完结
How I treat Philadelphia chromosome-like acute lymphoblastic leukemia in children, adolescents, and young adults
9小时前
已完结
Philadelphia-chromosome positive acute lymphoblastic leukemia: ten frequently asked questions
9小时前
已完结
Advances in the treatment of Philadelphia chromosome negative acute lymphoblastic leukemia
9小时前
已完结
Immunotherapy in first line treatment of adult acute lymphoblastic leukemia
9小时前
待确认
Treatment of ALK-rearranged non-small-cell lung cancer with brigatinib as second or later lines: real-world observations from a single institution
1天前
已完结
皖公网安备34019202002308
